ERBB2 and invasive breast carcinoma: Triple negative breast cancer (TNBC), defined by lack of expression of the ER, progesterone receptor (PgR), and HER2, accounts for 10–20% of invasive breast cancer, and carries a relatively worse prognosis, with higher rates of metastasis and recurrence, and higher mortality [33, 34].